HLTH daily end of the downtrendSell to Open HLTH Nov 18 2022 2.5 Put Limit at $0.10 (Good 'til Canceled)
HLTH daily end of the downtrend
−2.4401USD
−373.46 MUSD
70.94 MUSD
109.06 M
About Cue Health Inc.
Sector
Industry
CEO
Clint Sever
Website
Headquarters
San Diego
Employees (FY)
726
Founded
2010
ISIN
US2297901009
FIGI
BBG00LDMHH68
Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. The firms first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. The company was founded by Ayub Khattak and Clint Sever in 2010 and is headquartered in San Diego, CA.
$HLTH - Reversal play with +30% to +90% profit potential Technical Analysis
Another oversold play with huge upside
Price Target
Early entry: $3.66
Breakout Entry: $4.01
Price Target 1: $5.20 (+30%)
Price Target 2: 5.91 (+40%)
Price Target 3: 7.88 (+96%)
Analyst Target: $9 (125%)
Financials/Fundamental Analysis (FA)
Strong financial metric an
Cue HealthCue Health is a publicly-traded San Diego, California-based healthcare technology company that develops portable diagnostic tests for at-home use. The company developed the first FDA-authorized COVID-19 diagnostic test for at-home and over-the-counter use without a prescription and physician supervi
US Stock In Play: $HLTH$HLTH IPO Base pattern. relatively decent RS, trading below IPO AVWAP.
actionable trade for the upcoming week as it look poised for a breakout at $13.60
Omicron means more testingAfter falling below Ipo price, cue health will catch a bid if the omicron headline cycles for a few weeks.
$HLTH is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $19,01;
stop-loss — $1
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HLTH is 0.15 USD — it has decreased by 0.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cue Health Inc. stocks are traded under the ticker HLTH.
Cue Health Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Cue Health Inc. has a max estimate of 1.00 USD and a min estimate of 0.50 USD.
HLTH earnings for the last quarter are −0.42 USD whereas the estimation was −0.44 USD which accounts for 5.26% surprise. Estimated earnings for the next quarter are −0.43 USD. See more details about Cue Health Inc. earnings.
Cue Health Inc. revenue for the last quarter amounts to 17.48 M USD despite the estimated figure of 11.81 M USD. In the next quarter revenue is expected to reach 17.68 M USD.
Yes, you can track Cue Health Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, HLTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cue Health Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 726.00 employees. See our rating of the largest employees — is Cue Health Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cue Health Inc. EBITDA is −215.24 M USD, and current EBITDA margin is −338.95%. See more stats in Cue Health Inc. financial statements.